Sarah Elizabeth Reichard v. HHS - Tdap, Guillain-Barré syndrome (GBS) (2016)
Case summary [AI summaries can sometimes make mistakes]
Sarah Elizabeth Reichard filed a petition for vaccine compensation on September 25, 2014, alleging that the Tetanus-diphtheria-acellular pertussis (Tdap) vaccine she received on August 2, 2013, caused her to develop Guillain-Barré syndrome (GBS). The Tdap vaccine is listed on the Vaccine Injury Table.
Respondent denied that the vaccine caused Ms. Reichard's GBS or any other injury.
Despite this denial, the parties reached a joint stipulation to settle the case. The stipulation awarded Ms.
Reichard a lump sum of $85,000.00 for all damages available under the program. Additionally, a lump sum of $18,035.43 was awarded for attorneys' fees and costs, payable jointly to petitioner and her attorney, Kelly D.
Burdette of Burkett & Burdette. The decision adopting this stipulation was filed on March 8, 2016, by Special Master Christian J.
Moran. The case was resolved through a settlement, with the court adopting the parties' agreement on compensation.
The public decision does not describe the onset of symptoms, specific medical tests, or treatments. The specific mechanism of causation was not detailed in the public decision, but the Tdap vaccine is listed on the Vaccine Injury Table.
Source PDFs
USCOURTS-cofc-1_14-vv-00904